TwoStep Therapeutics
A peptide-targeting platform is advancing conjugate and radioligand therapies for solid tumors.
$62.5MSeries A
Role not disclosedActivity from announced rounds
A peptide-targeting platform is advancing conjugate and radioligand therapies for solid tumors.
Uses physics-based AI to unlock latent grid capacity and accelerate power delivery for AI data centers
Deepgram provides real-time voice APIs for speech recognition, speech synthesis and voice AI applications.